Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18651-18700 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04034459
FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab 1st-line in BRAF-mutated mCRC
PHASE2
Active, not recruiting
109 participants
Started: Nov 25, 2016 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT02977052
Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab
PHASE2
Active, not recruiting
186 participants
Started: Nov 24, 2016 · Completed: Jun 30, 2025
1 condition
2 sponsors
4 locations
NCT02525432
Autologous Stem Cell Study for Adult TBI (Phase 2b)
PHASE2
Active, not recruiting
37 participants
Started: Nov 21, 2016 · Completed: Jan 31, 2025
3 conditions
3 sponsors
1 location
NCT02937272
A Study of LY3200882 in Participants With Solid Tumors
PHASE1
Active, not recruiting
223 participants
Started: Nov 21, 2016 · Completed: Aug 31, 2026
1 condition
1 sponsor
18 locations
NCT02908906
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
PHASE1/PHASE2
Active, not recruiting
413 participants
Started: Nov 21, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
20 locations
NCT02717156
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
PHASE2
Active, not recruiting
103 participants
Started: Nov 21, 2016 · Completed: Nov 21, 2026
3 conditions
2 sponsors
9 locations
NCT02812524
Ipilimumab for Head and Neck Cancer Patients
PHASE1
Active, not recruiting
18 participants
Started: Nov 18, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02957890
Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong
PHASE4
Active, not recruiting
400 participants
Started: Nov 18, 2016 · Completed: Sep 30, 2026
1 condition
3 sponsors
1 location
NCT02845401
The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).
NA
Active, not recruiting
121 participants
Started: Nov 17, 2016 · Completed: May 31, 2026
1 condition
2 sponsors
2 locations
NCT02992912
Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
PHASE2
Active, not recruiting
138 participants
Started: Nov 15, 2016 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT04444128
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
N/A
Active, not recruiting
6,000 participants
Started: Nov 15, 2016 · Completed: Jun 30, 2030
4 conditions
4 sponsors
3 locations
NCT02884648
Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
PHASE2
Active, not recruiting
35 participants
Started: Nov 15, 2016 · Completed: Feb 1, 2026
4 conditions
2 sponsors
1 location
NCT02568553
Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma
PHASE1
Active, not recruiting
44 participants
Started: Nov 15, 2016 · Completed: Jun 30, 2026
26 conditions
1 sponsor
24 locations
NCT02779751
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
PHASE1
Active, not recruiting
100 participants
Started: Nov 14, 2016 · Completed: Dec 31, 2025
2 conditions
2 sponsors
24 locations
NCT02912572
Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer
PHASE2
Active, not recruiting
106 participants
Started: Nov 14, 2016 · Completed: Nov 30, 2026
1 condition
2 sponsors
4 locations
NCT03157635
Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria
PHASE1/PHASE2
Active, not recruiting
59 participants
Started: Nov 14, 2016 · Completed: Jan 31, 2026
1 condition
2 sponsors
14 locations
NCT02968732
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NA
Active, not recruiting
65 participants
Started: Nov 11, 2016 · Completed: Apr 1, 2027
1 condition
2 sponsors
1 location
NCT02792465
A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors
PHASE1
Active, not recruiting
52 participants
Started: Nov 11, 2016 · Completed: May 31, 2027
2 conditions
1 sponsor
3 locations
NCT02873962
A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib
PHASE2
Active, not recruiting
73 participants
Started: Nov 10, 2016 · Completed: Jan 31, 2027
3 conditions
3 sponsors
3 locations
NCT02911064
Expectations Regarding Mobility and Self-Care
N/A
Active, not recruiting
133 participants
Started: Nov 10, 2016 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT03182296
Visualizing Beta Cells in Patients With a History of Gestational Diabetes
NA
Active, not recruiting
24 participants
Started: Nov 10, 2016 · Completed: Jan 1, 2026
1 condition
1 sponsor
1 location
NCT02515383
Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version)
N/A
Active, not recruiting
41 participants
Started: Nov 9, 2016 · Completed: Apr 30, 2026
2 conditions
2 sponsors
1 location
NCT02744053
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
EARLY_PHASE1
Active, not recruiting
96 participants
Started: Nov 7, 2016 · Completed: Apr 30, 2026
4 conditions
2 sponsors
6 locations
NCT03646045
Transpyloric Feeding for Prevention of Micro-aspiration
N/A
Active, not recruiting
46 participants
Started: Nov 4, 2016 · Completed: Dec 15, 2025
2 conditions
1 sponsor
2 locations
NCT02935361
Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
PHASE1/PHASE2
Active, not recruiting
33 participants
Started: Nov 2, 2016 · Completed: Dec 31, 2026
3 conditions
3 sponsors
4 locations
NCT03610555
Creating a Patient-centered Report Card for Solid Organ Transplant Candidates
N/A
Active, not recruiting
1,000 participants
Started: Nov 1, 2016 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT03495232
Persona Cohort Nordic Multicenter Study
N/A
Active, not recruiting
700 participants
Started: Nov 1, 2016 · Completed: Dec 31, 2032
1 condition
1 sponsor
4 locations
NCT06390826
Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)
PHASE2
Active, not recruiting
10 participants
Started: Nov 1, 2016 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT04928170
The Halland Osteoarthritis Cohort
N/A
Active, not recruiting
312 participants
Started: Nov 1, 2016 · Completed: Dec 1, 2024
3 conditions
2 sponsors
1 location
NCT02817659
To Determine Tolerability to Glucagon Infusion in Obese Subjects
PHASE1
Active, not recruiting
20 participants
Started: Nov 1, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03077191
Toxicity and Outcome of Whole Breast Hypofractionated Radiotherapy: a Single Institution Experience
N/A
Active, not recruiting
410 participants
Started: Nov 1, 2016 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT02291523
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis
PHASE1
Active, not recruiting
101 participants
Started: Nov 1, 2016 · Completed: Nov 30, 2023
1 condition
1 sponsor
1 location
NCT03189420
Glioma Microenvironment an Exploratory Study
N/A
Active, not recruiting
30 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT02807805
Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
PHASE2
Active, not recruiting
37 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT02889523
Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy
PHASE1/PHASE2
Active, not recruiting
214 participants
Started: Oct 31, 2016 · Completed: Apr 30, 2026
3 conditions
2 sponsors
31 locations
NCT02685397
Management of Castration-Resistant Prostate Cancer with Oligometastases
PHASE2/PHASE3
Active, not recruiting
102 participants
Started: Oct 31, 2016 · Completed: Aug 31, 2041
1 condition
1 sponsor
11 locations
NCT02909777
Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
PHASE1
Active, not recruiting
26 participants
Started: Oct 31, 2016 · Completed: Oct 31, 2025
4 conditions
2 sponsors
4 locations
NCT02931084
Natural Course and Recovery After ACL-injury
N/A
Active, not recruiting
275 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02918955
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
PHASE3
Active, not recruiting
65 participants
Started: Oct 31, 2016 · Completed: May 31, 2025
1 condition
2 sponsors
2 locations
NCT02939612
Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial
NA
Active, not recruiting
200 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT02959502
Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression
NA
Active, not recruiting
40 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2025
5 conditions
2 sponsors
1 location
NCT02748434
Glucose Variability in Subclinical Hypertrophy
NA
Active, not recruiting
9 participants
Started: Oct 31, 2016 · Completed: Sep 1, 2025
2 conditions
2 sponsors
2 locations
NCT02998164
Improving Outcomes Using Technology for Children Who Are DHH
NA
Active, not recruiting
154 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2025
3 conditions
2 sponsors
2 locations
NCT02921022
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
NA
Active, not recruiting
110 participants
Started: Oct 31, 2016 · Completed: Oct 31, 2025
2 conditions
3 sponsors
10 locations
NCT02932280
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
PHASE1/PHASE2
Active, not recruiting
14 participants
Started: Oct 31, 2016 · Completed: Oct 31, 2025
4 conditions
8 sponsors
9 locations
NCT02908984
Specific Neck Rehabilitation for Unilateral Headache and Neck Pain, and Structural and Functional Changes in the Brain
NA
Active, not recruiting
57 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02944058
Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures
NA
Active, not recruiting
79 participants
Started: Oct 31, 2016 · Completed: Oct 25, 2025
2 conditions
1 sponsor
1 location
NCT02777476
Clinical Performance of B-Lite® Light Weight Breast Implant
NA
Active, not recruiting
120 participants
Started: Oct 31, 2016 · Completed: Dec 31, 2028
1 condition
1 sponsor
3 locations
NCT02741986
Integrating Data, Algorithms and Clinical Reasoning for Surgical Risk Assessment
N/A
Active, not recruiting
200 participants
Started: Oct 31, 2016 · Completed: Nov 30, 2028
1 condition
2 sponsors
2 locations
NCT02756793
Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancer (The STOP Trial)
NA
Active, not recruiting
90 participants
Started: Oct 31, 2016 · Completed: Jun 30, 2026
1 condition
1 sponsor
7 locations
Previous
1
More pages
371
372
373
374
375
376
377
More pages
431
Next